指南与共识瓣膜外科

非老年患者主动脉瓣置换术:现实、指南与证据之间的差距

Aortic valve replacement in non-elderly: the gap between reality, guidelines and evidence.
指南 / 共识 · Eur J Cardiothorac Surg · 2023-01-01

该研究通过43项在线问卷调查全球33个国家222名心脏外科医生和心脏病学家,评估其对18-60岁非老年患者主动脉瓣置换策略的当前观点与实践。结果显示机械瓣最常用,生物瓣随年龄增长更受欢迎,经导管主动脉瓣置换和Ross手术各用于不足10%的该队列,仅12%外科医生有Ross手术经验,23%患者似乎未参与瓣膜类型决策。作者认为需加强心脏科室协作及以患者为中心结局的教育与研究。

要点

  • 机械瓣是18-60岁非老年患者最常用的瓣膜替代物,生物瓣使用随年龄增长而增加。
  • 经导管主动脉瓣置换和Ross手术在该队列中各用于不足10%的患者。
  • 仅12%心脏外科医生有Ross手术经验,23%患者似乎未参与瓣膜类型决策。

核心结论

  • 需要主动脉瓣置换的非老年患者首选手术治疗方案差异很大。
  • 为实现包含患者偏好的共享决策,需要更多心脏科室间协作以及关于不同主动脉瓣置换技术以患者为中心结局的教育和科学研究。

研究设计与样本

  • 研究向多个科学组织、个体心脏外科医生、心脏病学家及住院医师/进修医生全球发送43项在线问卷。
  • 共222名来自33个不同国家的医生回答了问卷。
  • 英国(24%)、比利时(23%)和北美(22%)代表比例最高。

主要发现

  • 机械瓣是18-60岁非老年患者最常用的瓣膜替代物。
  • 随着患者年龄增加,生物瓣的受欢迎程度增加。
  • 经导管主动脉瓣置换和Ross手术在该队列中各用于不足10%的患者。
  • 仅12%的心脏外科医生有Ross手术经验。
  • 23%的患者似乎未参与瓣膜替代物类型的决策。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There are several treatment options for non-elderly adults (18-60 years) in need of aortic valve replacement (AVR): a mechanical or biological substitute, a homograft, the Ross procedure or nowadays even transcatheter aortic valve replacement. This study evaluated the current opinions and practices of cardiac surgeons and cardiologists concerning AVR strategies in this patient group. METHODS: A 43-item online survey was sent out to several scientific organizations, individual cardiac surgeons, cardiologists and residents/fellows worldwide. RESULTS: Two hundred twenty-two physicians from 33 different countries answered the survey. The UK (24%), Belgium (23%) and North America (22%) are best represented. A mechanical valve is the most frequently used substitute in non-elderly. With increasing patient age, the popularity of a biological valve increases. Transcatheter aortic valve replacement and the Ross procedure are each used in <10% of this cohort. Only 12% of the cardiac surgeons has experience with the Ross surgery. In 23%, the patient seems not to be involved in the decision on the type of valve substitute. CONCLUSIONS: The preferred surgical treatment for non-elderly patients in need of AVR differs widely. To enable a shared decision-making process including patient preferences, there is more need for collaboration between cardiac departments, as well as education and scientific research about patient-centred outcomes of the different AVR techniques.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Geuens L, Van Hoof L, Van De Bruaene A, et al. Aortic valve replacement in non-elderly: the gap between reality, guidelines and evidence. Eur J Cardiothorac Surg. 2023. PMID: 37756688. doi:10.1093/ejcts/ezad318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。